Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
THE SO WHAT
Isomorphic Labs is framing ‘cure cancer’ as an AI-native drug pipeline problem — compressing timelines, not just improving hit rates. For pharma and biotech operators, the bar for in-house computational biology just moved from optional to strategic hedge.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechBinance in Talks for Malaysia License after Five-Year Absence
Regulated re-entry after a ban is the new crypto playbook — licenses as the price of long-term market access. If you operate in or around digital assets, assume compliance and regulator relationships are now core infrastructure, not a bolt-on cost center.
Deep & Emerging TechA look at growing bipartisan opposition to AI data centers in drought-stricken Arizona, where TSMC's chip fabs were welcomed but newer projects face backlash
Water stress is turning AI data centers into political flashpoints — even in states that welcomed fabs and other industry. If your growth plan assumes hyperscale in constrained regions, you need a parallel track for water accounting, community benefits, and alternative siting before permits stall your roadmap.
Deep & Emerging TechJulien Camirand Lemire (Nord Quantique): One Cavity, One Error-Corrected Qubit
If Nord Quantique’s bosonic code can deliver one error-corrected qubit per superconducting cavity, the constraint shifts from qubit count to cavity yield and control electronics. For anyone with a 5–10 year quantum exposure, roadmap risk now includes which error-correction architecture your partners are implicitly betting on.
Deep & Emerging TechBinance Reassures Users That $6.3 Billion in Stolen Crypto Is, Like, Pocket Money to Them
A platform being able to freeze ~$3B of stolen tokens and casually backstop $6.3B of losses underscores how centralized the “decentralized” rails have become. If your business depends on crypto liquidity, counterparty risk is now about a few chokepoint venues, not protocols in the abstract.